BIRC3 and central nervous system cancer: Although these treatments have yet to be attempted in brain tumors, our results demonstrating BIRC3 as upregulated in HGG relative to LGG and its effect on promoting malignant progression in vivo highlights its potential as a therapeutic target in glioma.